Agreed. I'm sympathetic to the article's cause, but Pfizer/JNJ shareholders haven't done particularly well in the past couple decades. Since 2000, the CAGR for

Agreed. I'm sympathetic to the article's cause, but Pfizer/JNJ shareholders haven't done particularly well in the past couple decades. Since 2000, the CAGR for (PFI, JNJ, SPY, IWM) was (1.56%, 7.68%, 7.79%, 7.63%) respectively. (Per portfoliovisualizer.com. 2000 is the earliest date with data for IWM.)